﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Steven Nissen news stories on Newser</title><description>Read more Steven Nissen stories on Newser</description><link>http://www.newser.com/taggrid/2135/steven-nissen.html</link><image><url>http://img1-cdn.newser.com/images/newser-black250x40.gif</url><title>Steven Nissen news stories on Newser</title><link>http://www.newser.com/</link></image><copyright>2012 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Thu, 24 May 2012 15:55:02 CDT</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/2405/drug-company-nemesis-strikes-again.html</guid><title>Drug Company Nemesis Strikes Again</title><dc:creator>Sam Gale Rosen</dc:creator><description>&lt;img src='http://img1-cdn.newser.com/getimage.aspx?mediaid=5064&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035008' border='0' /&gt;The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug...</description><media:content url="http://img1-cdn.newser.com/getimage.aspx?mediaid=5064&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035008" type="image/jpg" medium="image"><media:description type="plain">Steven Nissen, M.D. poses at the 56th Annual American College of Cardiology Conference Scientific session in New Orleans, Monday, March 26, 2007. (AP Photo/Judi Bottoni)</media:description></media:content><link>http://www.newser.com/story/2405/drug-company-nemesis-strikes-again.html</link><pubDate>Tue, 22 May 2007 13:32:41 CDT</pubDate></item></channel></rss>
